Top Analyst Upgrades and Downgrades: Allergan, Amazon, Chipotle, Netflix, QIWI, Sarepta and More

July 22, 2014 by Jon C. Ogg

Stocks were staging a recovery on Tuesday and investors are again looking for upside and sectors where they feel safe. 24/7 Wall St. reviews dozens of analyst research reports each morning to find new investment and trading ideas for our readers. Some of the daily analyst reports cover stocks to buy, and some of them feature stocks to sell or to avoid.

These are this Tuesday’s top analyst upgrades, downgrades and initiations from Wall Street firms.

Allergan Inc. (NYSE: AGN) was raised to Buy from Neutral at UBS — the deal hope and talk continues.

Amazon.com Inc. (NASDAQ: AMZN) is due to report earnings in just two days, yet the online seller of everything was downgraded to Neutral from Buy at Citigroup.

American Axle & Manufacturing Holdings Inc. (NYSE: AXL) was raised to Neutral from Underweight at J.P. Morgan.

Arcos Dorados Holdings Inc. (NYSE: ARCO) was downgraded to Underweight from Neutral at HSBC.

Celestica Inc. (NYSE: CLS) was downgraded to Sector Underperform from Sector Perform at Scotia.

ALSO READ: 10 Brands That Will Disappear in 2015

Chipotle Mexican Grill (NYSE: CMG) rose after earnings and targets are being raised, with shares indicated up about 10% at $650. RBC raised its target to $730 from $680, Piper Jaffray to $740 from $610 and Baird to $800 from $650. Estimates were raised at Sterne Agee with a $742 price target.

Diamondback Energy Inc. (NASDAQ: FANG) was raised to Buy from Neutral with a $101 price target (versus a $87.99 close) at Roth Capital.

Digital Realty Trust Inc. (NYSE: DLR) was raised to Buy from Hold at Deutsche Bank and the price target was raised to $68 from $56 (versus a $61.23 close). Its yield is still 5.7% despite almost a 50% rise from its 52-week low.

Five Below Inc. (NASDAQ: FIVE) was raised to Outperform from Market Perform and given a $41 to $42 value (versus a $34.40 close) at Wells Fargo.

Halliburton Co. (NYSE: HAL) was reiterated as Buy and the price target was raised to $84 from $79 at Argus.

Huntington Bancshares Inc. (NASDAQ: HBAN) was raised to Outperform with a $11.50 price target (versus a $9.74 close) at Keefe Bruyette & Woods.

ALSO READ: GE’s Value and Identity Crisis for 2014 and 2015

Netflix Inc. (NASDAQ: NFLX) was mixed after earnings, but we have seen some analyst price targets lifted: RBC raised to $530 from $500 and FBR raised to $440 from $390. Sterne Agee maintained a Neutral but lowered estimates. Credit Suisse maintained a Neutral but raised its target to $430 from $369.

QIWI PLC (NASDAQ: QIWI) has been smacked due to its online payment system exposure in Russia, but the company was started as Positive with a price target of $50 (versus a $37.58 close) at Susquehanna.

Realogy Holdings Corp. (NYSE: RLGY) was raised to Buy from Neutral at Citigroup.

Sanmina Corp. (NASDAQ: SANM) was raised to Hold from Sell at Deutsche Bank.

Sarepta Therapeutics Inc. (NASDAQ: SRPT) was started as Neutral at Merrill Lynch, but the firm issued a $27 price objective (versus a $21.57 close) and it also said that it has significant potential but is very risky.

SunTrust Banks Inc. (NYSE: STI) downgraded to Equal Weight from Overweight at Evercore.

Valspar Corp. (NYSE: VAL) was raised to the prized Conviction Buy List at Goldman Sachs, but the hike was up all the way from Neutral. The price target was raised to $97 from $83, versus a $76.18 close.

ALSO READ: How Analysts and Investors Value Apple Ahead of Earnings

In case you missed Monday’s top analyst upgrades and downgrades, they included Apple, ARM Holdings, DaVita Healthcare, GE, GoPro, Itron, Regeneron Pharmaceuticals and many more.